Dividend Channel
Free Dividend Report - Top Ranked Stocks

PARTNER NEWS:

Tue, Mar 5, 12:00 PM, Zacks
FDA Lifts Clinical Hold on Iovance's (IOVA) Lung Cancer Study
The FDA removes the clinical hold on Iovance's (IOVA) mid-stage study on LN-145 in certain NSCLC patients after reviewing the company's proposal for additional safety measures and monitoring.

Mon, Mar 4, 10:51 AM, Zacks
J&J (JNJ) Secures Full FDA Nod for Rybrevant in Lung Cancer
The approval is based on data from a late-stage study wherein treatment with J&J's (JNJ) Rybrevant plus chemotherapy reduced the disease-progression risk or death by 61% in certain NSCLC patients.

Featured MNV Articles:

Lavoro Breaks Below 200-Day Moving Average - Notable for LVRO
Wednesday, March 27, 5:46 PM ET, by Market News Video Staff

In trading on Wednesday, shares of Lavoro Ltd (LVRO) crossed below their 200 day moving ...

Bullish Two Hundred Day Moving Average Cross - PCB
Wednesday, March 27, 5:46 PM ET, by Market News Video Staff

In trading on Wednesday, shares of PCB Bancorp (PCB) crossed above their 200 day moving ...

JAMF Makes Bullish Cross Above Critical Moving Average
Wednesday, March 27, 5:46 PM ET, by Market News Video Staff

In trading on Wednesday, shares of Jamf Holding Corp (JAMF) crossed above their 200 day ...

Bullish Two Hundred Day Moving Average Cross - HBT
Wednesday, March 27, 5:46 PM ET, by Market News Video Staff

In trading on Wednesday, shares of HBT Financial Inc (HBT) crossed above their 200 day ...

Blue Foundry Bancorp (BLFY) Shares Cross Above 200 DMA
Wednesday, March 27, 5:46 PM ET, by Market News Video Staff

In trading on Wednesday, shares of Blue Foundry Bancorp (BLFY) crossed above their 200 day ...

By Dividend Channel Staff, Wednesday, December 31, 7:00 PM ET
Play Video: The Importance of ETFs


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Email EnvelopeFree Email Alerts By Stock:
Get Dividend Alerts
Get SEC Filing Alerts


Dividend Channel | www.DividendChannel.com | Copyright © 2010 - 2024, All Rights Reserved

Nothing in Dividend Channel is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and dividend videos powered by Market News Video. Quote data delayed at least 20 minutes; data powered by Ticker Technologies, and Mergent. Contact Dividend Channel; Meet Our Editorial Staff.